Ibere Pharmaceuticals

Ibere Pharmaceuticals (ticker: IBER) is a pharmaceutical and life sciences-focused special purpose acquisition company that went public in 2021. On March 13, 2023, the company filed a Form 15-12G with the SEC — accession number 0001104659-23-031638 — initiating the termination of its Section 12(g) registration, a procedural step that typically marks the conclusion of a SPAC's registered reporting life following the expiration of its business combination window without a completed transaction. The deregistration filing reflects the company's wind-down of its blank-check structure in the healthcare and pharmaceutical sector. Sign up on SpacDesk for full data on IBER, including sponsor details, filing history, and deal activity across the SPAC universe.